Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyTue, 04 Jun 2024 05:59:02 +0200Wed, 20 Mar 2024 15:20:00 +0100Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 43, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/roactemraHuman medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 43, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/roactemraWed, 20 Mar 2024 15:20:00 +0100Human medicineRoActemra : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-955-en_0.pdfRoActemra : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-955-en_0.pdfWed, 20 Mar 2024 15:19:00 +0100Human medicine